产品名称 | NebuSelect™ Recombinant Human Siglec-15/CD33L3, hFc-tag |
---|---|
目录号 | NBL-242112 |
别名 | Siglec-15/CD33L3; CD33 molecule-like 3; CD33L3; HsT1361; Siglec15; CD33 antigen-like 3; SIGLEC-15 |
外观 | see COA |
分子量 | Lys24-Gly260 |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | Q6ZMC9-1 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-242112-100ug | 100ug | Inquire | Inquire | |
NBL-242112-1mg | 1mg | Inquire | Inquire | |
NBL-242112-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human Siglec-15/CD33L3, hFc-tag
Catalog#:
NBL-242112
Description:
NebuSelect™ Recombinant Human Siglec-15/CD33L3, hFc-tag(Cat#NBL-242112) is expressed in HEK293 with hFc tag at the C-Terminus.It contains Lys24-Gly260.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 52.6 kDa. Due to glycosylation, the protein migrates to 53-60 kDa based on Bis-Tris PAGE result.
Target Name:
Siglec-15/CD33L3; CD33 molecule-like 3; CD33L3; HsT1361; Siglec15; CD33 antigen-like 3; SIGLEC-15
Target Information:
Siglec-15 is a transmembrane glycoprotein in the Siglec family of sialic acid-binding immune regulatory molecules. Mature human Siglec-15 consists of a 244 amino acid extracellular domain (ECD) with two Ig-like domains, a 21 aa transmembrane segment, and a 44 aa cytoplasmic domain. Siglec-15 is a potential therapeutic target for osteoporosis and plays a conserved regulatory role in the immune system of vertebrates.
Amino Acid Sequence:
Lys24-Gly260
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.